These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 20029383

  • 41. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
    Liu Y, Zhou Y, Wang Y, Geng D, Liu J.
    Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
    [Abstract] [Full Text] [Related]

  • 42. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery.
    Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR.
    Obes Surg; 2010 Mar; 20(3):308-15. PubMed ID: 20217955
    [Abstract] [Full Text] [Related]

  • 43. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.
    Morínigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R, Vidal J.
    Obes Surg; 2006 Dec; 16(12):1594-601. PubMed ID: 17217635
    [Abstract] [Full Text] [Related]

  • 44. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H, Hannukainen JC, Iozzo P, Soinio M, Salminen P, Saunavaara V, Borra R, Parkkola R, Mari A, Lehtimäki T, Pham T, Laine J, Kärjä V, Pihlajamäki J, Nelimarkka L, Nuutila P.
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [Abstract] [Full Text] [Related]

  • 45. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives.
    Scheen AJ, De Flines J, De Roover A, Paquot N.
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):537-43. PubMed ID: 20152741
    [Abstract] [Full Text] [Related]

  • 46. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR.
    Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
    [Abstract] [Full Text] [Related]

  • 47. Gut hormone release after gastric bypass depends on the length of the biliopancreatic limb.
    Patrício BG, Morais T, Guimarães M, Veedfald S, Hartmann B, Hilsted L, Holst JJ, Nora M, Monteiro MP.
    Int J Obes (Lond); 2019 May; 43(5):1009-1018. PubMed ID: 29795464
    [Abstract] [Full Text] [Related]

  • 48. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
    De Bandt D, Rives-Lange C, Frigout Y, Bergerot D, Blanchard A, Le Gall M, Lacorte JM, Chevallier JM, Czernichow S, Poghosyan T, Carette C, Le Beyec J.
    Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
    [Abstract] [Full Text] [Related]

  • 49. Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
    Seyfried F, Miras AD, Rotzinger L, Nordbeck A, Corteville C, Li JV, Schlegel N, Hankir M, Fenske W, Otto C, Jurowich C.
    Obes Surg; 2016 Jun; 26(6):1228-36. PubMed ID: 26377340
    [Abstract] [Full Text] [Related]

  • 50. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A, Casamitjana R, Flores L, Delgado S, Lacy A, Vidal J.
    Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
    [Abstract] [Full Text] [Related]

  • 51. Foregut Exclusion Enhances Incretin and Insulin Secretion After Roux-en-Y Gastric Bypass in Adults With Type 2 Diabetes.
    Kirwan JP, Axelrod CL, Kullman EL, Malin SK, Dantas WS, Pergola K, Del Rincon JP, Brethauer SA, Kashyap SR, Schauer PR.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4192-e4201. PubMed ID: 33870426
    [Abstract] [Full Text] [Related]

  • 52. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
    Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ.
    Surg Obes Relat Dis; 2007 Sep 27; 3(6):597-601. PubMed ID: 17936091
    [Abstract] [Full Text] [Related]

  • 53. Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients.
    Umeda LM, Silva EA, Carneiro G, Arasaki CH, Geloneze B, Zanella MT.
    Obes Surg; 2011 Jul 27; 21(7):896-901. PubMed ID: 21559794
    [Abstract] [Full Text] [Related]

  • 54. Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass.
    Elahi D, Galiatsatos P, Rabiee A, Salas-Carrillo R, Vakilipour A, Carlson OD, Angeli FS, Shannon RP, Egan JM, Andersen DK.
    Surg Obes Relat Dis; 2014 Jul 27; 10(6):1028-39. PubMed ID: 25443077
    [Abstract] [Full Text] [Related]

  • 55. Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study.
    Nosso G, Griffo E, Cotugno M, Saldalamacchia G, Lupoli R, Pacini G, Riccardi G, Angrisani L, Capaldo B.
    Horm Metab Res; 2016 May 27; 48(5):312-7. PubMed ID: 26788926
    [Abstract] [Full Text] [Related]

  • 56. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M, Fändriks L, Vincent RP, Cross GF, le Roux CW, Olbers T.
    Surg Obes Relat Dis; 2014 May 27; 10(5):822-8. PubMed ID: 25282191
    [Abstract] [Full Text] [Related]

  • 57. Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.
    Zhang XJ, Xiao Z, Yu HL, Zhang XX, Cheng Z, Tian HM.
    Arch Med Res; 2013 Aug 27; 44(6):437-43. PubMed ID: 23973197
    [Abstract] [Full Text] [Related]

  • 58. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.
    Flynn CR, Albaugh VL, Tamboli RA, Gregory JM, Bosompem A, Sidani RM, Winnick JJ.
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb 01; 318(2):G370-G374. PubMed ID: 31709832
    [Abstract] [Full Text] [Related]

  • 59. Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction.
    Khoo CM, Muehlbauer MJ, Stevens RD, Pamuklar Z, Chen J, Newgard CB, Torquati A.
    Ann Surg; 2014 Apr 01; 259(4):687-93. PubMed ID: 23787216
    [Abstract] [Full Text] [Related]

  • 60. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat.
    Meirelles K, Ahmed T, Culnan DM, Lynch CJ, Lang CH, Cooney RN.
    Ann Surg; 2009 Feb 01; 249(2):277-85. PubMed ID: 19212182
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.